Safety and efficacy of brigatinib (AP26113) in advanced malignancies, including ALK+ non–small cell lung cancer (NSCLC).-Reference-Cited by-同舟云学术

Safety and efficacy of brigatinib (AP26113) in advanced malignancies, including ALK+ non–small cell lung cancer (NSCLC).

Published:2015-05-20 Issue:15_suppl Volume:33 Page:8062-8062
ISSN:0732-183X
Container-title:Journal of Clinical Oncology
language:en
Short-container-title:JCO

Author:

Camidge D. Ross¹,Bazhenova Lyudmila²,Salgia Ravi³,Langer Corey J.⁴,Gold Kathryn A.⁵,Rosell Rafael⁶,Shaw Alice Tsang⁷,Weiss Glen J.⁸,Narasimhan Narayana I.⁹,Dorer David J.⁹,Rivera Victor M.⁹,Clackson Timothy Piers¹⁰,Conlan Maureen G⁹,Kerstein David¹¹,Haluska Frank G.¹²,Gettinger Scott N.¹³

Affiliation:

1. University of Colorado Cancer Center, Aurora, CO

2. UC San Diego Moores Cancer Center, La Jolla, CA

3. The University of Chicago, Chicago, IL

4. Abramson Cancer Center of the University of Pennsylvania, Philadelphia, PA

5. The University of Texas MD Anderson Cancer Center, Houston, TX

6. Cancer Biology and Precision Medicine Program, Catalan Institute of Oncology, Hospital Germans Trias i Pujol, Badalona, Barcelona, Spain

7. Massachusetts General Hospital Cancer Center, Boston, MA

8. Western Regional Medical Center, Cancer Treatment Centers of America, Goodyear, AZ

9. ARIAD Pharmaceuticals, Inc., Cambridge, MA

10. Ariad Pharmaceuticals Inc, Cambridge, MA

11. ARIAD Pharmaceuticals, Inc, Cambridge, MA

12. ARIAD Pharmaceuticals, Cambridge, MA

13. Yale School of Medicine, New Haven, CT

Publisher

American Society of Clinical Oncology (ASCO)

Subject

Cancer Research,Oncology

Link

http://ascopubs.org/doi/pdfdirect/10.1200/jco.2015.33.15_suppl.8062

Cited by 34 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Clinical Trials for Oral, Inhaled and Intravenous Drug Delivery System for Lung Cancer and Emerging Nanomedicine-Based Approaches;International Journal of Nanomedicine;2023-12

2. Treatment of brain metastases in ALK-positive non-small cell lung cancer;Critical Reviews in Oncology/Hematology;2021-09

3. Central nervous system relapse in a child with anaplastic large cell lymphoma: potential for new therapeutic strategies;Cancer Reports;2021-04-06

4. Brigatinib: New-generation ALK inhibitor for nonsmall cell lung cancer;Current Problems in Cancer;2019-12

5. Novel Systemic Treatments for Brain Metastases From Lung Cancer;Current Treatment Options in Neurology;2018-09-27